Source: Business Wire

Press Release: Aphios : Aphios Awarded an NIH Grant For a Combination Therapeutic for Chronic Opioid Use Disorder Relapse

WOBURN, Mass.--(BUSINESS WIRE)-- #Biodegradable--Aphios announced today that it was awarded an NIH grant to develop a combination therapeutic for chronic opioid use disorder relapse. The United States of America is currently experiencing an opioid epidemic, which recently was referred to as an epidemic in the midst of a pandemic, exacerbated by the increased risk of overuse as a result of social and economic stress and disruptions in accessing medical treatments. Few therapeutics are available for individuals t

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Trevor P. Castor's photo - President & CEO of Aphios

President & CEO

Trevor P. Castor

CEO Approval Rating

89/100

Read more